CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-03 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Option exercise | +5,616 | 5,616 | ||
| 2022-05-03 | Jensen Claus Torp CHIEF INNOVATION OFFICER | Option exercise · Restricted Stock Units | −5,616 | 11,233 | ||
| 2022-05-01 | Raman-Tangella Vidya CHIEF MEDICAL OFFICER | Grant or award · Restricted Stock Units | +122,927 | 122,927 | ||
| 2022-04-01 | Napolitano Richard J CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +6,778 | 6,778 | ||
| 2022-04-01 | Napolitano Richard J CHIEF ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +6,778 | 6,778 | ||
| 2022-03-07 | Verstraete Stephany Chief Marketing Officer | Sale | −3,774 | $66.74 | $252K | 31,828 |
| 2022-03-07 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −3,879 | $66.74 | $259K | 11,983 |
| 2022-03-07 | Trencher Daniel SVP Corporate Strategy | Sale | −1,642 | $66.74 | $110K | 29,408 |
| 2022-03-07 | Turitz Andrew SVP - Business Development | Sale | −1,334 | $66.74 | $89K | 14,794 |
| 2022-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +3,701 | 30,791 | ||
| 2022-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise | +4,811 | 35,602 | ||
| 2022-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Restricted Stock Units | −3,701 | 0 | ||
| 2022-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Performance Stock Units | −4,811 | 0 | ||
| 2022-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +3,454 | 11,371 | ||
| 2022-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +4,491 | 15,862 | ||
| 2022-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Restricted Stock Units | −3,454 | 0 | ||
| 2022-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Performance Stock Units | −4,491 | 0 | ||
| 2022-03-04 | GOREVIC JASON N Chief Executive Officer | Option exercise | +16,778 | 494,652 | ||
| 2022-03-04 | GOREVIC JASON N Chief Executive Officer | Option exercise | +21,812 | 516,464 | ||
| 2022-03-04 | GOREVIC JASON N Chief Executive Officer | Option exercise · Restricted Stock Units | −16,778 | 0 |
Page 61 of 93 · 1,848 trades